Literature DB >> 12543672

MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action.

Libuse A Bobek1, Hongsa Situ.   

Abstract

This study was aimed at examining the spectrum of antimicrobial activity of MUC7 20-mer (N-LAHQKPFIRKSYKCLHKRCR-C; residues 32 to 51 of MUC7, the low-molecular-weight human salivary mucin, comprised of 357 residues) and comparing its antifungal properties to those of salivary histatin 5 (Hsn-5). We also examined the secondary structure of the 20-mer and the possible mechanism of its antifungal action. Our results showed that MUC7 20-mer displays potent killing activity against a variety of fungi and both gram-positive and gram-negative bacteria at micromolar concentrations. Time-dependent killing of Candida albicans and Cryptococcus neoformans by MUC7 20-mer and Hsn-5 indicated differences in killing rates between MUC7 20-mer and Hsn-5. The secondary structure prediction showed that MUC7 20-mer adopts an amphiphilic helix with distinguishable hydrophilic and hydrophobic faces (a characteristic that is associated with antimicrobial activity). In comparison to that of Hsn-5, the fungicidal activity of MUC7 20-mer against C. albicans seems to be independent of fungal cellular metabolic activity, as evidenced by its killing potency at a low temperature (4 degrees C) and in the presence of inhibitors of oxidative phosphorylation in the mitochondrial system. Fluorescence microscopy showed the ability of MUC7 20-mer to cross the fungal cell membrane and to accumulate inside the cells. The internalization of MUC7 20-mer was inhibited by divalent cations. Confocal microscopy of cells doubly labeled with MUC7 20-mer and a mitochondrion-specific dye indicated that mitochondria are not the target of MUC7 20-mer for either C. albicans or C. neoformans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543672      PMCID: PMC151741          DOI: 10.1128/AAC.47.2.643-652.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

Review 1.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides.

Authors:  Y Shai
Journal:  Biochim Biophys Acta       Date:  1999-12-15

2.  Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity.

Authors:  R Feder; A Dagan; A Mor
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

Review 3.  Antifungal peptides: potential candidates for the treatment of fungal infections.

Authors:  A J De Lucca
Journal:  Expert Opin Investig Drugs       Date:  2000-02       Impact factor: 6.206

Review 4.  Peptide antibiotics.

Authors:  R E Hancock; D S Chapple
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

5.  Characterization of histatin 5 with respect to amphipathicity, hydrophobicity, and effects on cell and mitochondrial membrane integrity excludes a candidacidal mechanism of pore formation.

Authors:  E J Helmerhorst; W van't Hof; P Breeuwer; E C Veerman; T Abee; R F Troxler; A V Amerongen; F G Oppenheim
Journal:  J Biol Chem       Date:  2000-11-30       Impact factor: 5.157

6.  Divergent solid-phase synthesis and candidacidal activity of MUC7 D1, a 51-residue histidine-rich N-terminal domain of human salivary mucin MUC7.

Authors:  J Satyanarayana; H Situ; S Narasimhamurthy; N Bhayani; L A Bobek; M J Levine
Journal:  J Pept Res       Date:  2000-11

7.  The recombinant N-terminal region of human salivary mucin MG2 (MUC7) contains a binding domain for oral Streptococci and exhibits candidacidal activity.

Authors:  B Liu; S A Rayment; C Gyurko; F G Oppenheim; G D Offner; R F Troxler
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

8.  In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.

Authors:  H Situ; L A Bobek
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

9.  Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans.

Authors:  S E Koshlukova; M W Araujo; D Baev; M Edgerton
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

10.  Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways.

Authors:  M Edgerton; S E Koshlukova; M W Araujo; R C Patel; J Dong; J A Bruenn
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

View more
  22 in total

1.  Host-derived pentapeptide affecting adhesion, proliferation, and local pH in biofilm communities composed of Streptococcus and Actinomyces species.

Authors:  Mirva Drobni; Tong Li; Carina Krüger; Vuokko Loimaranta; Mogens Kilian; Lennart Hammarström; Hans Jörnvall; Tomas Bergman; Nicklas Strömberg
Journal:  Infect Immun       Date:  2006-08-28       Impact factor: 3.441

2.  Immunocytochemical localization of MG1 mucin in human bulbourethral glands.

Authors:  M Piludu; A R Hand; M Cossu; M Piras
Journal:  J Anat       Date:  2009-01       Impact factor: 2.610

3.  [Expression of antimicrobial peptide MUC7 in kidneys with pyelonephritis].

Authors:  J Lehmann; H Suttmann; M Gerber; R Shayesteh-Kheslat; J Hartmann; M Hack; S Siemer; M Stöckle
Journal:  Urologe A       Date:  2006-10       Impact factor: 0.639

4.  Endocytosis-mediated vacuolar accumulation of the human ApoE apolipoprotein-derived ApoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans.

Authors:  Tristan Rossignol; Bridie Kelly; Curtis Dobson; Christophe d'Enfert
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

5.  Elucidating the role of hyposalivation and autoimmunity in oral candidiasis.

Authors:  M Billings; B A Dye; T Iafolla; M Grisius; I Alevizos
Journal:  Oral Dis       Date:  2017-02-08       Impact factor: 3.511

6.  Human salivary mucin MUC7 12-mer-L and 12-mer-D peptides: antifungal activity in saliva, enhancement of activity with protease inhibitor cocktail or EDTA, and cytotoxicity to human cells.

Authors:  Guo-Xian Wei; Libuse A Bobek
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 7.  Functions of ocular surface mucins in health and disease.

Authors:  Flavio Mantelli; Pablo Argüeso
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-10

8.  Chemical genomic screening of a Saccharomyces cerevisiae genomewide mutant collection reveals genes required for defense against four antimicrobial peptides derived from proteins found in human saliva.

Authors:  Maciej Lis; Sanjay Bhatt; Nathan E Schoenly; Anna Y Lee; Corey Nislow; Libuse A Bobek
Journal:  Antimicrob Agents Chemother       Date:  2012-12-03       Impact factor: 5.191

Review 9.  Histidine phosphotransfer proteins in fungal two-component signal transduction pathways.

Authors:  Jan S Fassler; Ann H West
Journal:  Eukaryot Cell       Date:  2013-06-14

10.  Human salivary MUC7 mucin peptides: effect of size, charge and cysteine residues on antifungal activity.

Authors:  Hongsa Situ; Guoxian Wei; Christina J Smith; Shirin Mashhoon; Libuse A Bobek
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.